Medtronic plc (MDT)
Market Open
2 Sep, 18:58
$
93. 10
+1.06
+1.1517%
$
116.78B Market Cap
25.14 P/E Ratio
2.84% Div Yield
471,511 Volume
5.2 Eps
$ 92.04
Previous Close Want to track MDT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
MDT trading today higher at $93.1, an increase of 1.1517% from yesterday's close, completing a monthly increase of 7.2457% or $6.29. Over the past 12 months, MDT stock lost -2.9905%.
MDT pays dividends to its shareholders, with the most recent payment made on Jul 17, 2026. The next announced payment will be in In 1 month on Oct 16, 2026 for a total of $0.72.
The last earnings report, released on May 20, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.0267%, based on the last three reports.
Medtronic plc has completed 7 stock splits, with the recent split occurring on Sep 27, 1999.
The company's stock is traded on 14 different exchanges and in various currencies, with the primary listing on NYSE (USD).
MDT Q1 Earnings Call Focuses on Broad Growth, Raised Guidance
Medtronic raises its fiscal 2027 outlook as growth broadens across major franchises and newer platforms, with robotics and ablation investments advancing.
Zacks | 3 hours ago
Why Medtronic (MDT) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks | 4 hours ago
Medtronic's Stars Are Aligning for a Price Recovery
Medtronic NYSE: MDT is a good buy in late 2026 because stars such as value, growth, guidance, partnerships, and dividends are aligning. They point to sustained outperformance and potential acceleration but, more importantly, to robust capital returns.
Marketbeat | 1 day ago
Medtronic plc Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| TJD Thomas John Drogan PR Inc.IPAL SECURITIES Inc. | 75,385 | $6.4M | $7.05M | $649,601.13 | 10.16% |
| DI David Izzi Brown, LISLE/CUMMINGS Inc. | 1,237 | $108,982.41 | $115,616.2 | $6,633.79 | 6.09% |
 Michelle S. Hickox FIRST FINANCIAL BANKSHARES Inc. | 752,965 | $62.87M | $70.31M | $7.44M | 11.83% |
 Timothy M. Bidwell Hazlett, BURT & WATSON Inc. | 1,046 | $89,502.92 | $97,445.36 | $7,942.44 | 8.87% |
| LC Lisa Candera CIGNA INVESTMENTS Inc. /NEW | 12,062 | $1.24M | $1.12M | -$112,897.48 | -9.13% |
Medtronic plc (MDT) FAQ
What is the stock price today?
The current price is $93.10.
On which exchange is it traded?
Medtronic plc is listed on NYSE.
What is its stock symbol?
The ticker symbol is MDT.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 2.84%.
What is its market cap?
As of today, the market cap is 116.78B.
Has Medtronic plc ever had a stock split?
Medtronic plc had 7 splits and the recent split was on Sep 27, 1999.
Medtronic plc Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | Geoffrey Straub Martha CEO | NYSE Exchange | G5960L103 CUSIP |
| IE Country | 95,000 Employees | 25 Sep 2026 Last Dividend | 27 Sep 1999 Last Split | 13 Jan 1978 IPO Date |
Overview
Medtronic plc is a global leader in medical technology, specializing in the development, manufacture, and sale of device-based medical therapies. Serving healthcare systems, physicians, clinicians, and patients around the world, the company is dedicated to alleviating pain, restoring health, and extending life for millions of people. Founded in 1949 and headquartered in Dublin, Ireland, Medtronic operates across various medical domains through its diverse portfolio which includes cardiovascular, medical surgical, neuroscience, and diabetes treatments and technologies.
Products and Services
Medtronic’s comprehensive range of products and services is categorized into four primary segments:
- Cardiovascular Portfolio: This segment offers advanced device-based solutions for cardiac care, including:
- Implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices for heart rhythm management.
- Cardiac ablation products for treating atrial fibrillation.
- Insertable cardiac monitor systems for continuous heart monitoring.
- TYRX products, which involve antimicrobial envelopes for electronic implantable devices.
- Aortic valves, surgical valve replacement and repair products, transcatheter pulmonary valves, and endovascular stent grafts for structural heart disease treatment.
- Percutaneous coronary intervention products and angioplasty balloons for coronary artery disease treatment.
- Remote monitoring and patient-centered software for enhanced patient care.
- Medical Surgical Portfolio: This segment encompasses a broad array of surgical instruments and devices, including:
- Surgical stapling devices and vessel sealing instruments for precise surgical procedures.
- Wound closure products and electrosurgery products aimed at efficient surgical recovery.
- Surgical artificial intelligence and robotic-assisted surgery products for advanced surgical techniques.
- Hernia mechanical devices and mesh implants, along with other gynecology and lung health products.
- Minimally invasive gastrointestinal and hepatologic diagnostic and therapy tools, patient monitoring, airway management and ventilation therapies, and renal disease treatments.
- Neuroscience Portfolio: This segment delivers solutions for the central nervous system and supportive structures, including:
- Products for spinal, neuro, and orthopedic surgeries, pain management, and urology.
- Energy surgery instruments and image-guided surgery systems for enhanced surgical accuracy.
- Intra-operative imaging and robotic guidance systems for spine procedures.
- Therapies for brain vasculature conditions.
- Diabetes Operating Unit: Focused on diabetes management, this segment offers:
- Insulin pumps and consumables for continuous insulin delivery.
- Continuous glucose monitoring systems for real-time blood glucose tracking.
- Smart insulin pen systems and related consumables for modern diabetes care.
Contact Information
Address: Building Two, Parkmore Business Park West
Phone: 353 1 438 1700
Website: https://www.medtronic.com
